These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19789420)

  • 1. Pioglitazone reduces ER stress in the liver: direct monitoring of in vivo ER stress using ER stress-activated indicator transgenic mice.
    Yoshiuchi K; Kaneto H; Matsuoka TA; Kasami R; Kohno K; Iwawaki T; Nakatani Y; Yamasaki Y; Shimomura I; Matsuhisa M
    Endocr J; 2009; 56(9):1103-11. PubMed ID: 19789420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct monitoring of in vivo ER stress during the development of insulin resistance with ER stress-activated indicator transgenic mice.
    Yoshiuchi K; Kaneto H; Matsuoka TA; Kohno K; Iwawaki T; Nakatani Y; Yamasaki Y; Hori M; Matsuhisa M
    Biochem Biophys Res Commun; 2008 Feb; 366(2):545-50. PubMed ID: 18070597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines.
    Das SK; Chu WS; Mondal AK; Sharma NK; Kern PA; Rasouli N; Elbein SC
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E393-400. PubMed ID: 18544642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemic effect of polysaccharide enriched extract of Astragalus membranaceus in diet induced insulin resistant C57BL/6J mice and its potential mechanism.
    Mao XQ; Yu F; Wang N; Wu Y; Zou F; Wu K; Liu M; Ouyang JP
    Phytomedicine; 2009 May; 16(5):416-25. PubMed ID: 19201177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.
    Kubota N; Terauchi Y; Kubota T; Kumagai H; Itoh S; Satoh H; Yano W; Ogata H; Tokuyama K; Takamoto I; Mineyama T; Ishikawa M; Moroi M; Sugi K; Yamauchi T; Ueki K; Tobe K; Noda T; Nagai R; Kadowaki T
    J Biol Chem; 2006 Mar; 281(13):8748-55. PubMed ID: 16431926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adipose tissue endocrine mechanism of the prophylactic protective effect of pioglitazone in high-fat diet-induced insulin resistance.
    Gong Y; Li J; Li C; Mu Y; Xiao Y; Tian H; Pan C; Liu Y
    J Int Med Res; 2012; 40(4):1304-16. PubMed ID: 22971482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of ER stress in retinal cell death.
    Shimazawa M; Inokuchi Y; Ito Y; Murata H; Aihara M; Miura M; Araie M; Hara H
    Mol Vis; 2007 Apr; 13():578-87. PubMed ID: 17438523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic Mice.
    Maganti AV; Tersey SA; Syed F; Nelson JB; Colvin SC; Maier B; Mirmira RG
    J Biol Chem; 2016 Oct; 291(43):22524-22533. PubMed ID: 27613867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats.
    Hsieh YL; Yao HT; Cheng RS; Chiang MT
    J Med Food; 2012 May; 15(5):453-60. PubMed ID: 22439875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone-induced increase in the stearoyl-CoA desaturation index and fat accumulation in rat muscles are not related to lipoprotein lipase activity.
    Ochiai M; Matsuo T
    J Oleo Sci; 2013; 62(9):745-54. PubMed ID: 24005019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
    Shen X; Li H; Li W; Wu X; Ding X
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone.
    Nankar RP; Doble M
    Phytomedicine; 2017 Dec; 37():4-9. PubMed ID: 29103827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice.
    Tang Y; Osawa H; Onuma H; Nishimiya T; Ochi M; Makino H
    Diabetes; 1999 Sep; 48(9):1830-5. PubMed ID: 10480615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of liver endoplasmic reticulum stress in a modified choline-deficient l-amino acid-defined diet-fed non-alcoholic steatohepatitis mouse model.
    Muraki Y; Makita Y; Yamasaki M; Amano Y; Matsuo T
    Biochem Biophys Res Commun; 2017 May; 486(3):632-638. PubMed ID: 28322783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
    Kanatani Y; Usui I; Ishizuka K; Bukhari A; Fujisaka S; Urakaze M; Haruta T; Kishimoto T; Naka T; Kobayashi M
    Diabetes; 2007 Mar; 56(3):795-803. PubMed ID: 17327450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress.
    Ishida H; Takizawa M; Ozawa S; Nakamichi Y; Yamaguchi S; Katsuta H; Tanaka T; Maruyama M; Katahira H; Yoshimoto K; Itagaki E; Nagamatsu S
    Metabolism; 2004 Apr; 53(4):488-94. PubMed ID: 15045697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice.
    Zhang C; Chen X; Zhu RM; Zhang Y; Yu T; Wang H; Zhao H; Zhao M; Ji YL; Chen YH; Meng XH; Wei W; Xu DX
    Toxicol Lett; 2012 Aug; 212(3):229-40. PubMed ID: 22698815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.
    Bajaj M; Suraamornkul S; Hardies LJ; Glass L; Musi N; DeFronzo RA
    Diabetologia; 2007 Aug; 50(8):1723-31. PubMed ID: 17520238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus.
    Defronzo RA; Mehta RJ; Schnure JJ
    Hosp Pract (1995); 2013 Apr; 41(2):132-47. PubMed ID: 23680744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.